Effectiveness of screening colonoscopy in reducing the risk of death from right and left colon cancer: A large community-based study

Gut

Volumn 67, Issue 2, 2018, Pages 291-298

  Doubeni, Chyke A ^a   Corley, Douglas A ^b   Quinn, Virginia P ^c   Jensen, Christopher D ^b   Zauber, Ann G ^d   Goodman, Michael ^e   Johnson, Jill R ^a   Mehta, Shivan J ^a   Becerra, Tracy A ^c   Zhao, Wei K ^b   Schottinger, Joanne ^c   Doria Rose, V Paul ^f   Levin, Theodore R ^b   Weiss, Noel S ^g   Fletcher, Robert H ^h  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b DIVISION OF RESEARCH   (United States)

^c KAISER PERMANENTE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e EMORY UNIVERSITY   (United States)

^f NATIONAL CANCER INSTITUTE   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

Author keywords

ADENOCARCINOMA; COLONOSCOPY; COLORECTAL CANCER; SCREENING

Indexed keywords

ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER MORTALITY; CASE CONTROL STUDY; CLINICAL EFFECTIVENESS; CLINICAL STUDY; COLON CANCER; COLONOSCOPY; COLORECTAL CANCER; COMMUNITY SAMPLE; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY RISK; NESTED CASE CONTROL STUDY; PRIORITY JOURNAL; RECTUM CANCER; RISK REDUCTION; VERY ELDERLY; ASCENDING COLON; CALIFORNIA; COLON TUMOR; DESCENDING COLON; DIAGNOSTIC IMAGING; EARLY CANCER DIAGNOSIS; EPIDEMIOLOGY; MORTALITY; PATHOLOGY; RECTUM TUMOR; RISK FACTOR; SIGMOID; SIGMOIDOSCOPY; STATISTICS AND NUMERICAL DATA; TRANSVERSE COLON;

AGED; AGED, 80 AND OVER; CALIFORNIA; CASE-CONTROL STUDIES; COLON, ASCENDING; COLON, DESCENDING; COLON, SIGMOID; COLON, TRANSVERSE; COLONIC NEOPLASMS; COLONOSCOPY; EARLY DETECTION OF CANCER; FEMALE; HUMANS; MALE; MIDDLE AGED; RECTAL NEOPLASMS; RISK FACTORS; SIGMOIDOSCOPY;

EID: 84994589724     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-312712     Document Type: Article

References (45)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7-30.
2. Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015;65:87-108.
3. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med 1993;328:1365-71.
4. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996;348:1472-7.
5. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467-71.
6. Segnan N, Armaroli P, Bonelli L, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the Italian Randomized Controlled Trial-SCORE. J Natl Cancer Inst 2011;103:1310-22.
7. Atkin WS, Edwards R, Kralj-Hans I, et al. Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial. Lancet 2010;375:1624-33.
8. Schoen RE, Pinsky PF, Weissfeld JL, et al. Colorectal-cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med 2012;366:2345-57.
9. Holme Ø, Løberg M, Kalager M, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA 2014;312:606-15.
10. Doubeni CA, Laiyemo AO, Reed G, et al. Socioeconomic and racial patterns of colorectal cancer screening among Medicare enrollees in 2000 to 2005. Cancer Epidemiol Biomarkers Prev 2009;18:2170-5.
11. Fedewa SA, Goodman M, Flanders WD, et al. Elimination of cost-sharing and receipt of screening for colorectal and breast cancer. Cancer 2015;121:3272-80.
12. Schenck AP, Peacock SC, Klabunde CN, et al. Trends in colorectal cancer test use in the medicare population, 1998-2005. Am J Prev Med 2009;37:1-7.
13. Goodman M, Fletcher RH, Doria-Rose VP, et al. Observational methods to assess the effectiveness of screening colonoscopy in reducing right colon cancer mortality risk: SCOLAR. J Comp Eff Res 2015:;4:541-51.
14. Bibbins-Domingo K, Grossman DC, Curry SJ, et al., US Preventive Services Task Force. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA 2016;315:2564-75.
15. Baxter NN, Goldwasser MA, Paszat LF, et al. Association of colonoscopy and death from colorectal cancer. Ann Intern Med 2009;150:1-8.
16. Baxter NN, Warren JL, Barrett MJ, et al. Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol 2012;30:2664-9.
17. Singh H, Nugent Z, Demers AA, et al. The reduction in colorectal cancer mortality after colonoscopy varies by site of the cancer. Gastroenterology 2010;139: 1128-37.
18. Kaminski MF, Bretthauer M, Zauber AG, et al. The NordICC Study: rationale and design of a randomized trial on colonoscopy screening for colorectal cancer. Endoscopy 2012;44:695-702.
19. Quintero E, Castells A, Bujanda L, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med 2012;366:697-706.
20. Dominitz JA, Robertson DJ. Colonoscopy versus fecal immunochemical test in reducing mortality from colorectal cancer (CONFIRM). 2012;NCT01239082.
21. Uppsala University Hospital. Colonoscopy and FIT as colorectal cancer screening test in the average risk population. ClinicalTrialsgov 2014;NCT02078804.
22. Wallace MB, Kiesslich R. Advances in endoscopic imaging of colorectal neoplasia. Gastroenterology 2010;138:2140-50.
23. Nishihara R, Wu K, Lochhead P, et al. Long-term colorectal-cancer incidence and mortality after lower endoscopy. N Engl J Med 2013;369:1095-105.
24. Doubeni CA, Weinmann S, Adams K, et al. Screening colonoscopy and risk for incident late-stage colorectal cancer diagnosis in average-risk adults: a nested case-control study. Ann Intern Med 2013;158(Pt 1):312-20.
25. Bacchus CM, Dunfield L, Gorber SC, et al. Canadian Task Force on Preventive Health Care. Recommendations on screening for colorectal cancer in primary care. CMAJ 2016;188:340-8.
26. Selby JV, Friedman GD, Quesenberry CP Jr, et al. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
27. U. S. Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;137:129-31.
28. U. S. Preventive Services Task Force. Screening for colorectal cancer: U. S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-37.
29. Lipton LR, Johnson V, Cummings C, et al. Refining the Amsterdam Criteria and Bethesda Guidelines: testing algorithms for the prediction of mismatch repair mutation status in the familial cancer clinic. J Clin Oncol 2004;22:4934-43.
30. Umar A, Boland CR, Terdiman JP, et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004;96:261-8.
31. Fassil H, Adams KF, Weinmann S, et al. Approaches for classifying the indications for colonoscopy using detailed clinical data. BMC Cancer 2014;14:95.
32. Doubeni CA, Schootman M, Major JM, et al. Health status, neighborhood socioeconomic context, and premature mortality in the United States: The National Institutes of Health-AARP Diet and Health Study. Am J Public Health 2012;102: 680-8.
33. Doubeni CA, Jambaulikar GD, Fouayzi H, et al. Neighborhood socioeconomic status and use of colonoscopy in an insured population-a retrospective cohort study. PLoS ONE 2012;7:e36392.
34. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-19.
35. Lieberman D, Nadel M, Smith RA, et al. Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of The National Colorectal Cancer Roundtable. Gastrointest Endosc 2007;65:757-66.
36. Rex DK, Bond JH, Winawer S, et al. Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U. S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 2002;97:1296-308.
37. Hogue CJ, Gaylor DW, Schulz KF. Estimators of relative risk for case-control studies. Am J Epidemiol 1983;118:396-407.
38. Weiss NS. Commentary: Cohort studies of the efficacy of screening for cancer. Epidemiology 2015;26:362-4.
39. Weiss NS. Commentary: case-control studies of screening for colorectal cancer: tailoring the design and analysis to the specific research question. Epidemiology 2013;24:894-7.
40. Eldridge RC, Doubeni CA, Fletcher RH, et al. Uncontrolled confounding in studies of screening effectiveness: an example of colonoscopy. J Med Screen 2013;20:198-207.
41. Corley DA, Jensen CD, Marks AR, et al. Adenoma detection rate and risk of colorectal cancer and death. N Engl J Med 2014;370:1298-306.
42. Mehta SJ, Jensen CD, Quinn VP, et al. Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med 2016; In press.
43. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112:594-642.
44. Zauber AG, Winawer SJ, O'Brien MJ, et al. Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687-96.
45. Knudsen AB, Zauber AG, Rutter CM, et al. Estimation of benefits, burden, and harms of colorectal cancer screening strategies: modeling study for the US preventive services task force. JAMA 2016;315:2595-609.